ZETAGEN THERAPEUTICS
ZetaGen Therapeutics is commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway. ZetaGen Therapeutics's goal is to halt cancer, reduce pain, and rebuild bones. The company's solution has the potential to revolutionize the treatment of bone-related injuries, operations, and diseases, resulting in better outcomes for both patients and doctors.
ZETAGEN THERAPEUTICS
Industry:
Health Care Medical Device Therapeutics
Founded:
2015-01-01
Address:
Syracuse, New York, United States
Country:
United States
Website Url:
http://www.zetagen.com
Total Employee:
11+
Status:
Active
Contact:
401-699-9402
Total Funding:
14.36 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt SSL By Default
Similar Organizations
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
flipMD
Connecting physicians to side gigs. Built by physicians for physicians.
InnaMed
Launching HomeLab, a gateway to personalized healthcare in the comfort and privacy of your home. Measure + Analyze + Enhance.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
OYS Mobility
OYS Mobility develops prosthetic technology that allows people with limb loss or deformity to access healthcare and assistive devices.
Pression
Medical device company improving blood flow volume body-wide using smart compression with initial focus on heart failure patients.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Zenflow
Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.
Current Employees Featured
Founder
Investors List
Consolidated Investment Group
Consolidated Investment Group investment in Series B - ZetaGen Therapeutics
New York Ventures
New York Ventures investment in Series B - ZetaGen Therapeutics
New York Ventures
New York Ventures investment in Series B - ZetaGen Therapeutics
National Cancer Institute
National Cancer Institute investment in Grant - ZetaGen Therapeutics
MedTech Innovator
MedTech Innovator investment in Seed Round - ZetaGen Therapeutics
Official Site Inspections
http://www.zetagen.com
- Host name: server.beresponsive.ca
- IP address: 162.223.228.26
- Location: Toronto Canada
- Latitude: 43.6683
- Longitude: -79.4205
- Timezone: America/Toronto
- Postal: M6G
More informations about "ZetaGen Therapeutics"
Zetagen | Our Company | About Zetagen | Private Clinical-Stage …
Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company dedicated to developing breakthrough therapies via local administration for metastatic and …See details»
ZetaGen Therapeutics - Crunchbase Company Profile
ZetaGen Therapeutics is commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway. ZetaGen Therapeutics's goal is to halt cancer, reduce …See details»
Zetagen Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Zetagen Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
ZetaGen Therapeutics Company Profile 2024: Valuation, Funding ...
ZetaGen Therapeutics has raised $20.3M. Who are ZetaGen Therapeutics’s investors? New York Ventures , National Institutes of Arthritis and Musculoskeletal Diseases, National Institutes of …See details»
Zetagen Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Zetagen Therapeutics, Inc. of Syracuse, NY. Get the latest business insights from Dun & Bradstreet.See details»
Walk With You | Zetagen
At Zetagen, we do what we do because we commit to Walk with You. Our first “Compassionate Use” patient was Colleen Connor. This is her story: As we walked with Colleen, we journeyed …See details»
Zetagen Therapeutics - VentureRadar
" Zetagen Therapeutics is a clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic cancers to bone and other organs as …See details»
Zetagen | Research Overview | Compassionate Use Access
The research behind Zetagen. Preclinical research resulting in a Breakthrough Device Designation award to ZetaMet for metastatic breast cancer. Zetagen. Our Company. The …See details»
ZetaGen Therapeutics - Contacts, Employees, Board Members
ZetaGen Therapeutics has 4 current employee profiles, including Co-Founder & Chief Medical Officer Nikhil Thakur. Nikhil Thakur Co-Founder & Chief Medical Officer Joe Loy Chief …See details»
Zetagen Therapeutics - Overview, News & Similar companies
Who is Zetagen Therapeutics. Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of m …See details»
Zetagen Therapeutics Inc. Profile - Medical XPRT
Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic …See details»
Zetagen Therapeutics Secures 9.79 Million USD Series B Funding …
Aug 11, 2023 Zetagen exclusively-licensed the platform technology from the State University of New York in 2016. The Company was recently issued IP directly associated with the …See details»
ZetaGen - Company Profile - Tracxn
Nov 4, 2024 ZetaGen ranks 8th among 79 active competitors. 16 of its competitors are funded while 17 have exited. Overall, ZetaGen and its competitors have raised over $892M in funding …See details»
ZetaGen Therapeutics Company Profile: Overview and Full News …
Zetagen Therapeutics, a private, clinical-stage, biopharmaceutical company, today announced publication of early, human clinical data in the peer-reviewed journal Pain Management on …See details»
ZetaGen Company Profile - MedTech Innovator
ZetaGen’s first product, ZetaFuse™, is a drug-device combination product that has been designated as a device by FDA and utilizes components with well-established clinical safety …See details»
ZetaMet™ Receives Health Canada Authorization for Phase 2a …
Jan 19, 2022 Syracuse, New York – Zetagen Therapeutics, a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of …See details»
Zetagen Therapeutics to conduct a Phase 2a study of ZetaMet™
January 18th, 2022, (Syracuse New York) - Zetagen Therapeutics, a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of …See details»
Zetagen | News | Keep up to date with the latest from Zetagen …
November 12, 2024, (Syracuse, New York) – Zetagen Therapeutics, Inc., a private, clinical stage, biopharmaceutical company focused on developing breakthrough therapies, via local …See details»
Inductive Biologic Inhibiting Bone Metastases - Zetagen
Zetagen has discovered and patented the discovery of a new molecular pathway of a well establish small molecule, as well as, novel carriers and NEW chemical entities. Through this …See details»